Cargando…
Piperlongumine, a Potent Anticancer Phytotherapeutic, Induces Cell Cycle Arrest and Apoptosis In Vitro and In Vivo through the ROS/Akt Pathway in Human Thyroid Cancer Cells
SIMPLE SUMMARY: There is no effective treatment currently available for patients with anaplastic, recurrent papillary, or follicular thyroid cancers. Reactive oxygen species (ROS) are believed to hold promise as a new therapeutic strategy for multiple human cancers. However, studies on ROS inducers...
Autores principales: | Kung, Fang-Ping, Lim, Yun-Ping, Chao, Wen-Ying, Zhang, Yi-Sheng, Yu, Hui-I, Tai, Tsai-Sung, Lu, Chieh-Hsiang, Chen, Shu-Hsin, Li, Yi-Zhen, Zhao, Pei-Wen, Yen, Yu-Pei, Lee, Ying-Ray |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428232/ https://www.ncbi.nlm.nih.gov/pubmed/34503074 http://dx.doi.org/10.3390/cancers13174266 |
Ejemplares similares
-
Piperlongumine Suppresses Proliferation of Human Oral Squamous Cell Carcinoma through Cell Cycle Arrest, Apoptosis and Senescence
por: Chen, San-Yuan, et al.
Publicado: (2016) -
Piperlongumine Induces Cellular Apoptosis and Autophagy via the ROS/Akt Signaling Pathway in Human Follicular Thyroid Cancer Cells
por: Lin, Tsung-Hsing, et al.
Publicado: (2023) -
Piperlongumine Inhibits Akt Phosphorylation to Reverse Resistance to Cisplatin in Human Non-Small Cell Lung Cancer Cells via ROS Regulation
por: Zhang, Chao, et al.
Publicado: (2019) -
Identification of Piperlongumine as Potent Inhibitor of Necroptosis
por: He, Xiaoyan, et al.
Publicado: (2023) -
Piperlongumine Analogs Promote A549 Cell Apoptosis through Enhancing ROS Generation
por: Sun, Ai-Ling, et al.
Publicado: (2021)